Local therapy with combination TLR agonists stimulates systemic anti-tumor immunity and sensitizes tumors to immune checkpoint blockade. - Rwandamuriye FX; Wang T; Zhang H; Elaskalani O; Kuster J; Ye X; Vitali B; Schreurs J; Orozco Morales ML; Norret M; Evans CW; Zemek RM; et al. (Oncoimmunology, 2024)